21851-76-3

Upstream product

• 6399-81-1 triphenylphosphine hydrobromide 
• 95-13-6 1-indene 
• 38256-56-3 1-(2-bromo-ethyl)-2-bromomethyl-benzene 
• 603-35-0 triphenylphosphine 
• 6351-10-6 1-Indanol 
• 83-33-0 inden-1-one 
• 21844-32-6 1-(2-Brom-ethyl)-2-triphenylphosphoniomethyl-benzol-bromid 

Downstream Products

• 1279722-78-9 C₁₆H₁₃N₃ 
• 1233340-90-3 (E)-1-((1-(phenylethynyl)cyclopentyl)methylene)-2,3-dihydro-1H-indene 
• 1091596-30-3 methyl 4-{2-[3,5-dichloro-6-(2,3-dihydro-1H-inden-1-ylidenemethyl)-2-oxopyridin-1(2H)-yl]ethyl}benzoate 
• 6399-81-1 triphenylphosphine hydrobromide 
• 95-13-6 1-indene 

Relevant academic research and scientific papers

Novel reaction course of alkenes to phosphonium salts

The reaction of styrenes with triphenylphosphine in the presence of acid gave the corresponding 1-arylethylphosphonium salts in 76-82% yields. Indene also reacted with triphenylphosphine and tetrafluoroboric acid to afford 1-indanyltriphenylphosphonium te

Rhodium-catalyzed synthesis of 2,3-disubstituted indoles from β,β-Disubstituted stryryl azides

Rings la carte: Rhodium carboxylate complexes catalyze selective cascade reactions to produce a range 2,3-disubstituted indoles from β,β- disubstituted stryryl azides. The selective migration of aryl groups appears to originate from a putative phenonium ion reactive intermediate (see scheme).

Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/- indanes and structurally modified derivatives: Potent and selective inhibitors of aldosterone synthase

Elevated aldosterone levels are key effectors for the development and progression of congestive heart failure and myocardial fibrosis. Recently, we proposed inhibition of aldosterone synthase (CYP11B2) as an innovative strategy for the treatment of these

Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: Potent inhibitors of aldosterone synthase

Elevated plasma aldosterone levels play a detrimental role in certain forms of congestive heart failure and myocardial fibrosis. We proposed aldosterone synthase (CYP11B2) as a novel target for the treatment of these diseases. In this study, the synthesis

A SYNTHESIS OF 2-METHYLENEINDANE

After difficulties encountered in a conventional Wittig approach, a synthesis of 2-methyleneindane was achieved via a β-silylsulphone intermediate.